Your session is about to expire
← Back to Search
Opioid Analgesic
hemodialysis for Chronic Kidney Disease (OCKD Trial)
Phase 4
Waitlist Available
Led By Oscar A Linares, MD
Research Sponsored by Emerio & Lourdes Linares Research and Education Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up t=0 to t=4 hours
Awards & highlights
OCKD Trial Summary
To measure oxycodone's intradialytic mass transfer rate coefficient and oxycodone's removal rate using an ODE/PDE hemodialysis model. To implement a rational clinical strategy for estimating a patient's post-hemodialysis oxycodone restoration dose using results from an ODE/PDE model of hemodialysis.
Eligible Conditions
- Chronic Kidney Disease
OCKD Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ t=0 to t=4 hours
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~t=0 to t=4 hours
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Oxycodone's intradialytic mass transfer coefficient
Side effects data
From 2022 Phase 4 trial • 393 Patients • NCT0412244322%
Drowsiness
8%
Dizziness
7%
Nausea
1%
Fatigue
1%
Itchiness
1%
Palpitations
1%
Shakiness
100%
80%
60%
40%
20%
0%
Study treatment Arm
Ibuprofen and Then Oxycodone/Acetaminophen (Stage 2)
Ibuprofen and Then Acetaminophen (Stage 2)
Ibuprofen (Stage 1)
OCKD Trial Design
2Treatment groups
Experimental Treatment
Group I: hemodialysisExperimental Treatment1 Intervention
Oxycodone will be administered and subjects will undergo hemodialysis
Group II: controlExperimental Treatment1 Intervention
Oxycodone will be administered and subjects will undergo hemodialysis
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Oxycodone
FDA approved
Find a Location
Who is running the clinical trial?
Emerio & Lourdes Linares Research and Education CenterLead Sponsor
Oscar A Linares, MDPrincipal InvestigatorEmerio & Lourdes Linares Research and Education Center
Share this study with friends
Copy Link
Messenger